Role of vasoactive drugs in the treatment of bleeding oesophageal varices

Digestion

Volumn 60, Issue SUPPL. 3, 1999, Pages 25-34

  Goulis, John ^a   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Octreotide; Randomised controlled trial; Sclerotherapy; Somatostatin; Terlipressin; Treatment; Variceal bleeding; Vasoactive drug; Vasopressin

Indexed keywords

GLYCERYL TRINITRATE; OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN;

ARTICLE; CEREBROVASCULAR DISEASE; DRUG EFFICACY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MESENTERY; META ANALYSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; SURVIVAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032721776     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051486     Document Type: Article

References (70)

1. Grace ND: Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081-1091.
2. The North Italian Endoscopie Club for the Study and Treatment in Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: A prospective multicenter study. N Engl J Med 1988;319:983-989.
3. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytic review. Hepatology 1995;22:332-354.
4. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat J-L: Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865-868.
5. Cooperative Spanish-French Group for the Treatment of Bleeding Esophageal Varices: Randomised controlled trial comparing terlipressin vs endoscopie injection sclerotherapy in the treatment of acute variceal bleeding and prevention of early rebleeding (abstract). Hepatology 1997;26:249A.
6. Sung JJY, Chung Sc S, Lai CW, Chan Fk L, Leung Jw C, Yung MY, Kassianidcs C, Li Ak C: Octreotidc infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993; 342:637-641.
7. Planas R, Quer JC, Boix J, Canet J, Armengol M. Cabre E, Pintanel T, Humbert P, Oller B, Broggi MA, Gassul MA: A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994;20:370-375.
8. Armonis A, Patch D, Burroughs AK: Hepatic venous pressure measurement: An old test as a new prognostic marker in cirrhosis? Hepatology 1997;25:245-248.
9. Robbins J, Breslow N, Greenland S: Estimators of the Mantel-Haenszel variance consistent in both sparse data and large strata limiting models. Biometrics 1986;42:311-323.
10. Der Simonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials 1986;7: 177-188.
11. Merigan TC Jr, Poltkin JR, Davidson CS: Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. N Engl J Med 1962;266: 134-135.
12. Conn HO, Ramsby GR, Storer EH, Mutchnick MG, Joshi PH, Phillips MM, Cohen GA, Fields GN, Petroski D: Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: A prospective, controlled clinical trial. Gastroenterology 1975;68:211-221.
13. Mallory A, Schaefer JW, Cohen JR, Holt AS, Norton LW: Selective intra-arterial vasopressin infusion for upper gastrointestinal tract hemorrhage: A controlled trial. Arch Surg 1980;115:30-32.
14. Fogel RM, Knauer CM, Andress LL: Continuous intravenous vasopressin in active upper gastrointestinal bleeding: A placebo controlled trial. Ann Intern Med 1982;96:565-569.
15. Bosch J, Groszmann RJ, Garcia-Pagan JC, Tercs J, Garcia-Tsao G, Navasa M. Mas A, Rodes J: Association of transdermal nitroglyccrin to vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial. Hepatobgy 1989;10:962-968.
16. Tsai YT, Lay CS, Lai KH, Ng WW, Yen YS, Wang JY, Chiang TT, Lee SD, Chiang BN, Lo KJ: Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices. Hepatology 1986;6:406-409.
17. Gimson AE, Westaby D, Hegarty J, Watson A, Williams R: A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology 1986;6:410-413.
18. Walker S, Stiehl A, Raedsch R, Kommerell B: Terlipressin in bleeding esophageal varices: A placebo-controlled, double-blind study. Hepatology 1986;6:112-115.
19. Freeman JG, Cobden MD, Record CO: Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989;11:58-60.
20. Soderlund C, Magnusson I, Torngren S, Lundell L: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices: A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990;25: 622-630.
21. Freeman JG, Cobden MD, Lishaman AH, Record CO: Controlled trial of tcrlipressin ('glypressin') versus vasopressin in the early treatment of esophageal varices. Lancet 1982;ii:62-68.
22. Desaint B, Florent C, Levy VG: A randomized trial of triglycyl-lysine vasopressin versus lysine vasopressin in active cirrhotic variceal hemorrhage; in Lebrec D, Blei AT (eds): Vasopressin Analogs and Portal Hypertension. Paris, Libbey Eurotext, 1987, pp 155-157.
23. Lee FY, Tsai YT, Lai KH, Lay CS, Chang TT, Malik U, Lin CY, et al: A randomized controlled study of triglycyl-vasopressin and vasopressin plus nitroglycerin in the control of acute esophageal variceal hemorrhage. Chin J Gastroenterol 1988;5:131-138.
24. Chiu WK, Sheen IS, Liaw YF: A controlled study of glypressin versus vasopressin in the control of bleeding from esophageal varices. J Gastroenterol Hepatol 1988;5:549-553.
25. D'Amico G, Traina M, Vizzini G, Tine F, Polti F. Montalbano L, Luca A, et al: Teripressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. J Hepatol 1994;20:206-212.
26. Colin R, Giuli N, Czcrnichow P, Ducrotte P, Lerebours E: Prospective comparison of glyprcssin, tamponade and their association in the treatment of bleeding esophageal varices; in Lebrec D, Blei AT (eds): Vasopressin Analogs and Portal Hypertension. Paris, Libbey Eurotext, 1987, pp 149-153.
27. Fort E, Sauterau D, Silvaine C, Ingrand P, Pillegrand B, Beauchant M: A randomized trial of terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal haemorrhage. Hepatology 1990;11:678-681.
28. Blanc P, Bories J, Desprez D, Pageaux GP, David XR, Diaz D, Larrey D, Michel H: Balloon tamponade with Linton-Michel tube versus terlipressin in the treatment of acute ocsophageal and gastric variceal bleeding (abstract). J Hepatol 1994;21:S133.
29. Brunati S, Ceriani R, Curioni R, Brunelli L, Repaci G, Morini L: Sclerotherapy alone vs sclerotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal haemorrhage (abstract). Hepatology 1996; 24:207A.
30. Sonnenburg GE, Keller U, Perruchud A, Burcharth F: Effect of somatostatin on splanchnic haemodynamics. Gastroenterology 1981;80: 5226-5232.
31. Bosch J, Kravetz D, Rodes J: Effects of somatostatin on hepatic and systemic haemodynamics inpatients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981;80:518-525.
32. Variceal Bleeding Study Group: A multicenter randomized controlled trial comparing different schedules of somatostatin administration in the treatment of acute variceal bleeding (abstract). Hepatology 1998;28:770A.
33. Valenzuela JE, Schubert T, Fogel RM, Strong RM, Levine J, Mills PR: A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989;10:958-961.
34. Burroughs AK, McCormick PA, Hughes MD, Sprengers S, D'Heygere F, McIntyre N: Randomised, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388-1395.
35. Gotzsche PC, Gjorup I, Bonnen H, Brahe Ne B, Becker U, Burcharth F: Somatostatin vs. placebo in bleeding esophageal-varices: Randomized trial and metaanalysis. Br Med J 1995;310:1495-1498.
36. Testoni PA, Masci E, Passaretti S, Malesci A, Tittobcllo A, Comin U, Ballarin E: Comparison of somatostatin and cimetidine in the treatment of acute esophageal variceal bleeding. Curr Ther Res 1986;39:759-766.
37. Loperfido S, Godena F, Tosolini G, Dematte P, Burei F, Gasparini G, Sartori C, Valbusa A, Bulfoni A, Buttolo Q: Somatostatin in the treatment of hemorrhaging esophago-gastric varices. Controlled clinical trial in comparison with ranitidine (in Italian). Rec Prog Med 1987;78:82-86.
38. Flati G, Negro P, Flati D, Porowska B, Tuscano D, Hidalgo Pascual M, Carboni M: Somatostatin. Massive upper digestive hemorrhage in portal hypertension. Results of a controlled study (in Spanish). Rev Esp Enfermed Aparato Digest 1986;70:411-414.
39. Kravetz D, Bosch J,Teres J, Bruix J, Rimola A. Rodes J: Comparison of intravenous somatostatin and vasopressin infusion in treatment of acute variceal hemorrhage. Hepatology 1984;4: 442-446.
40. Jenkins SA, Baxter JN, Corbett W, Devitt P, Ware J, Shields R: A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J 1985;290:275-278.
41. Bagarani M, Albertini V, Anza M, Barlattani A, Bracci F, Cucchiara G, Gizzonio D, et al: Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci 1987; 17:21-26.
42. Cardona C, Vida F, Balanzo J, Cusso X, Farre A, Guarner C: Efficacia terapeutica de la somatostatina versus vasopressina mas nitroglycerina en la hemorragia activa por varices esofa-gogastrica. Gastroenterol Hepatol 1989;12:30-34.
43. Hsia HC, Lee FY, Tsai YT, Lee SD, Lai KH, Lin WJ, Lay CS, et al: Comparison of somatostatin and vasopressin in the control of acute esophageal variceal hemorrhage. A randomized, controlled study. Chin J Gastroenterol 1990;7:71-78.
44. Saari A, Klvilaasko E, Inberg M, Paakkonen M, Lahtinem J, Hockerstedt K, Schroder T: Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol 1990;85:804-807.
45. Rodriguez-Moreno F, Santolaria F, Gles-Reimers E, Gomez JL, Batista N, Conde A, Martinez A: A randomized trial of somatostatin vs vasopressin plus nitroglycerin in the treatment of acute variceal bleeding (abstract). J Hepatol 1991;13:S162.
46. Feu F, DelArbol LR, Banares R, Planas R, Bosch J, Mas A, Escorsell A, Garcia Pagan JC, Bordas JM, Salmeron JM, Rodes J, Monescillo A, Vicente M, Garcia Plaza A, Casado M, Clemente G, Menchen P, Cos E, Quer JC, Boix J, Humbert P, Gassull MA: Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1996;111:1291-1299.
47. Walker S, Kreichgauer HP, Bode JC: Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices: Final report of a placebo-controlled, double-blind study. Z Gastroenterol 1996;34:692-698.
48. Jaramillo JL, de la Mata M, Mino G, Costan G, Gomez-Comacho F: Somatostatin versus Sengstaken tube balloon tamponade for primary haemostasis of bleeding esophageal varices: A randomized pilot study. J Hepatol 1991;12: 100-105.
49. Avgerinos A, Klonis C, Rekoumis G, Gouma P, Papadimitriou N, Raptis S: A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol 1991;13:78-83.
50. Di Febo G, Siringo S, Vacirca M, Santoro P, Merichi S, Mustafa A, Barbara L: Somatostatin (SMS) and urgent sclerotherapy (US) in active oesophageal variceal bleeding (abstract). Gastroenterology 1990;98:583A.
51. Shields R, Jenkins SA, Baxter JN, Kingsnorth AN, Ellenbogen S, Makin CA, Gilmore I, Morris AI, Ashby D, West CR: A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding esophageal varices. J Hepatol 1992;16:128-137.
52. Escorcell A, Bordas JM, Ruiz del Arbol L, Jaramillo JL, Planas R, Banares R, Albillos A, Bosch J, Members of the Variceal Bleeding Study Group: Randomized controlled trial of sclerotherapy vs somatostatin infusion in the prevention of early rebleeding following variceal hemorrhage in patients with cirrhosis. J Hepatol 1998;29:779-788.
53. Avgerinos A, Nevens F, Raptis S, Fevery J, ABOVE Study Group: Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350;1495-1499.
54. Signorelli S, Negrini F, Paris B, Bonelli M, Girola M: Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: Our experience (abstract). Gastroenterology 1996;110:1326A.
55. Jenkins SA, Baxter JN, Snowden S: The effects of somatostatin and SMS 201-995 on hepatic haemodynamics inpatients with cirrhosis and portal hypertension. Fibrinolysis 1988:2:48-50.
56. McCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, Burroughs AK: Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990;2:489-492.
57. McKee R: A study of octreotide in oesophageal varices. Digestion 1990;45(suppl 1):60-64.
58. Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, Wang SS, Lee SD, Tsai YT, Lo KJ: A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992;16:320-325.
59. Silvain C, Carpentier S, Sautereau D, Czernichow B, Metreau JM, Fort E, Ingrand P, Boyer J, Pillegand B, Doffel M, Dhumeaux D, Beauchant M: Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from esophageal-varices - a multicenter randomized trial. Hepatology 1993;18:61-65.
60. Poo JL, Bosques F. Garduno R, Marin E, Moran MA, Bobadilla J, Maldonado EP, Morales D, Garcia-Cantu D, Uribe M: Octreotide versus emergency sclerotherapy in acute variceal hemorrhage in liver cirrhosis (abstract). Gastroenterology 1996;110:1297A.
61. Kravetz D, Group for the Study of Portal Hypertension: Octreotide vs. sclerotherapy in the treatment of acute variceal bleeding (abstract). Hepatology 1996;24:206A.
62. Jenkins SA, Shields R, Davies M, Elias E, Turnbull AJ, Bassendine MF, James OFW, Iredale JP, Vyas SK, Arthur MJP, Kingsnorth AN, Sutton R: A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997;41:526-533.
63. El-Jackie A, Rowaisha I, Waked I, Saleh S, Abdel Ghaffar Y: Octreotide vs. sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: A randomized trial (abstract). Hepatology 1998;28: 533A.
64. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P, Larricq J, Gourlaouen A, Ribard D, Kara NM, Legoux JL, Pillegand B. Becker MC, Dicostanzo J, Metreau JM, Silvain C, Beauchant M: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-560.
65. Signorelli S, Paris B, Negrini F, Bonelli M, Auriemma L: Esophageal varices bleeding: Comparison between treatment with sclerotherapy alone vs. sclerotherapy plus octreotide (abstract). Hepatology 1997;26:137A.
66. Sung JJY, Chung SSC, Yung MY, Lai CW, Lau JYW, Lee YT, Leung VKS: Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopie ligation. Lancet 1995;346:1666-1669.
67. Burroughs A K, Patch D: Therapeutic benefit of vaso-active drugs for acute variceal bleeding: A real pharmacological effect, or a side-effect of definitions in trials? Hepatology 1996;24:737-739.
68. Burroughs AK, International Octreotide Varices Study Group: Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures (abstract). Hepatology 1996;24:352A.
69. Primignani M, Andreoni B, Carpinelli L, Capria A, Rocchi G, Lorenzini I, Staudacher C, Beretta L, Motta R, Defranchis R, Arcidiacono PG, Benedetti G, Carlucci M, Casadei A, Cosentino F, Geloni M, Gerunda G. Lacchin T, Lomazzi A, Maiolo P, Marini A, Miglio F, Mosca P, Nolte A, Rivolta R, Sablich R, Santambrogio R, Spina G, Tognini L, Vitagliano P: Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal-varices: A randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 1995;21:1322-1327.
70. D'Amico G, Politi F, Morabito A, D'Antoni A, Guerrera G, Giannuoli G, Traina M, Vizzini G, Pasta L, Pagliaro L, Liver Study Group of V Cervello Hospital: Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis: A double-blind, randomized pragmatic trial. Hepatology 1998;28: 1206-1214.